Loading
Clarivate PLC Stock: price and insider trades · United States
1 insider bought €1.4M of shares over the last 90 days, the latest filed 10 Aug 2026.
Clarivate PLC: what insiders have been doing
Clarivate PLC is a Business Services company. Its directors and officers file their transactions with SEC (Form 4). In the past year (18 October 2025 to 18 October 2026), 61 filings came from 16 insiders.
On the market, 2 insiders bought (5 purchases totalling €7.4M) while 2 insiders sold (4 sales totalling €5.2M). Taken together, the purchases exceed the sales by €2.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 2 senior executives. Snyder Andrew Miles filed the largest purchase, €4.2M, on 3 November 2025.
Compared with its exchange (5,812 companies, median 19 filings), a count of 61 filings is above the norm. Our records for Clarivate PLC go back to 2021, with 14 purchases and 18 sales on the open market in total. The 10-K for the year ended 31 December 2025 shows 2.46 bn USD of revenue and -201.1 m USD of net income.
In all, 3 purchases were made within 30 days of a purchase by another insider of the company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The most recent open-market purchase was published on 10 August 2026, 69 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction.
For comparison within the same sector, see the insider buying recorded at Coursera, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
296
Thresholds
n/a
Buy Volume
€20M
14 ops. · all time
Sell Volume
€242M
18 ops. · all time
Who traded when
BuySaleAndrew Miles Snyder2 buys3 sales
Kenneth L. Cornick5 buys
Angelakis Michael J1 buy
Jane L. Okun Bomba1 buy
Samson James Gordon1 sale
Saurabh Saha1 buy
+2 other insiders
Since the insiders bought
- -7.3%Entry US$1.91 · Close 15 Oct 2026 US$1.77
- -23.9%Entry US$3.48 · Close at T+90 US$2.65
- -42.5%Entry US$4.24 · Close at T+365 US$2.44
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Clarivate PLC Hold (neutral), based on 6 analysts. Average price target: US$2.97.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 13,576 of 24,148 companies
48.0
score / 100
Value62
Quality34
FCF yld35%
Earn yld-20%
EV/EBITDA6.6x
ROE-7.0%
Gross mgn66%
Net mgn-8.2%
Debt/EBITDA5.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$1.61
Analyst consensus
6 analystsHold
US$2.00Target US$2.97(+84%)US$5.50
Income statement
RevenueUS$2.5B
Gross profitUS$1.6B66% margin
EBITDAUS$828.7M34% margin
Net income-US$201.1M-13.8% margin
Valuation
PER (forward)2.1x
P/Book0.2x
Beta1.40
Balance sheet & cash
Market capUS$1B
Total debtUS$4.5B
Free Cash FlowUS$365.3M
Debt / Equity94%
Profitability & ownership
ROE-7.0%
ROA0.9%
% insiders18.3%
% institutions93.1%
Last declaration on 8 October 2026
Declarations296 total
263,576 shares@ US$1.470.041% mcap25.5% of flowOrdinary SharesSEC:0001764046-26-000119:0
17,215 shares@ US$1.670.0028% mcap3.5% of flowOrdinary SharesSEC:0001764046-26-000112:0
30,688 shares@ US$1.670.0050% mcap0.4% of flowOrdinary SharesSEC:0001764046-26-000111:0
17,215 shares@ US$1.670.0028% mcap0.7% of flowOrdinary SharesSEC:0001764046-26-000113:0
3,444 shares@ US$1.670.0006% mcap0.1% of flowOrdinary SharesSEC:0001764046-26-000113:1
181 shares@ US$1.670.0000% mcap0.0% of flowOrdinary SharesSEC:0001764046-26-000112:1
1,012 shares@ US$1.670.0002% mcap0.0% of flowOrdinary SharesSEC:0001764046-26-000111:1
194,300 shares0Ordinary SharesSEC:0001764046-26-000106:0
67,357 shares0Ordinary SharesSEC:0001764046-26-000107:0
47,633 shares@ US$1.960.0078% mcap19.7% of flowOrdinary SharesSEC:0001764046-26-000103:0
650,000 shares@ US$1.860.10% mcap27.4% of flowOrdinary SharesSEC:0001764046-26-000099:0
Canonical exit: 4 Nov 2026 (T+90)
250,000 shares@ US$1.850.039% mcap10.5% of flowOrdinary SharesSEC:0001764046-26-000099:1
Canonical exit: 5 Nov 2026 (T+90)
310,702 shares@ US$1.940.051% mcap4.2% of flowOrdinary SharesSEC:0001764046-26-000097:0
176,674 shares@ US$1.940.029% mcap2.4% of flowOrdinary SharesSEC:0001764046-26-000097:1
2,002,242 shares@ US$1.940.33% mcap26.8% of flowOrdinary SharesSEC:0001764046-26-000097:2
2,489,618 shares@ US$1.980.41% mcap100.0% of flowOrdinary SharesSEC144:0001968582-26-000775
13,310 sharesOrdinary SharesSEC:0001764046-26-000083:0
386 sharesOrdinary SharesSEC:0001764046-26-000083:1
396,825 sharesOrdinary SharesSEC:0001764046-26-000079:0
62,264 shares0Ordinary SharesSEC:0001764046-26-000070:1
62,264 shares0Ordinary SharesSEC:0001764046-26-000066:1
62,264 shares0Ordinary SharesSEC:0001764046-26-000067:1
62,264 shares0Ordinary SharesSEC:0001764046-26-000068:1
62,264 shares0Ordinary SharesSEC:0001764046-26-000069:1
62,264 shares0Ordinary SharesSEC:0001764046-26-000071:1
25 of 296 declarations
About Clarivate PLC
Clarivate Plc (NYSE: CLVT) is a global business services, data and workflow software company with a U.S.-listed security traded on the NYSE and an operating footprint that spans multiple regions. From an international equity perspective, Clarivate should be viewed less as a traditional software vendor and more as a provider of mission-critical “transformative intelligence” built on proprietary datasets, analytics and expert services. The company serves three core end markets: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. Clarivate’s current corporate structure dates to 2016, when the business emerged from the separation of Thomson Reuters assets, and the company was later incorporated in 2019 under Jersey law. Its functional headquarters are in London, while its market listing is in the United States on the NYSE under the ticker CLVT. Clarivate highlights a global workforce of more than 12,000 experts across 40+ countries and more than 45,000 customers in 180+ countries, underscoring the international scale of its franchise. ([clarivate.com](https://clarivate.com/about-us/?utm_source=openai))
Clarivate’s portfolio is organized around enriched data, insights and analytics, workflow solutions, and expert services. Its best-known assets include Web of Science, a leading citation and research intelligence platform used by universities and research institutions; Derwent, a highly regarded patent-search and patent-analytics solution; CompuMark, which supports trademark screening, watching and lifecycle management; and Cortellis, which provides intelligence for pharmaceutical and broader life sciences decision-making. The acquisition of ProQuest expanded Clarivate’s reach into academic libraries, scholarly content and research workflows, broadening the company’s relevance across institutions and researchers. These products are deeply embedded in client workflows, which helps support recurring revenue characteristics and customer retention. ([clarivate.com](https://clarivate.com/products/scientific-and-academic-research/research-discovery-and-workflow-solutions/webofscience-platform/web-of-science-core-collection/?utm_source=openai))
Read moreShow less
On a competitive basis, Clarivate operates in specialized markets with meaningful barriers to entry: trusted data quality, long historical datasets, brand credibility and high switching costs. In academic research, it competes on the depth and trustworthiness of its citation and discovery tools; in intellectual property, it supports law firms and corporate IP teams; and in life sciences, it helps customers identify opportunities, manage evidence and accelerate commercialization. Its geographic presence is global, with customers and operating resources distributed across the Americas, EMEA and Asia-Pacific, reducing reliance on any single country or region. ([clarivate.com](https://clarivate.com/about-us/?utm_source=openai))
Recent developments show that Clarivate is continuing to reposition the platform toward higher-value analytics and AI-enabled products. In 2025 and 2026, the company issued quarterly results and launched several initiatives, including Web of Science Research Intelligence and Nexus Connect, while also promoting new medtech insights. This points to an ongoing product refresh focused on institutional research, decision support and AI-enabled workflows. For investors, CLVT combines globally diversified recurring revenue streams with a portfolio of entrenched brands, but execution remains important, especially in converting product innovation into sustainable growth and margin improvement. ([clarivate.com](https://clarivate.com/news/clarivate-reports-first-quarter-2026-results/?utm_source=openai))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
